ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet
RxNorm concept 1375379, clinical drug (scd). Prescribable name: iron carbonyl (as iron) 65 MG / ascorbic acid 125 MG Delayed Release Oral Tablet.
- RxCUI
- 1375379
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1375379 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
vit-C 125 MG / Iron Carbonyl 65 MG Delayed Release Oral Tablet; vitamin c 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet
Related concepts
- ascorbic acid 125 MG (SCDC, consists of)
- iron carbonyl 65 MG (SCDC, consists of)
- Delayed Release Oral Tablet (DF, has dose form)
- ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1375379 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1375379 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1375379. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.